Search research articles
Contact Us
Filters
Showing results (91-100 of 93) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 93 results.
Gynecologic Oncology
|
June 1, 2021
OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer
E Frangou, G Bertelli, S Love, et al.
Journal of Bone Oncology
|
December 29, 2018
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
R E Coleman, M Collinson, W Gregory, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 93) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 93 results.
Gynecologic Oncology
|
June 1, 2021
OVPSYCH2: A randomized controlled trial of psychological support versus standard of care following chemotherapy for ovarian cancer
E Frangou, G Bertelli, S Love, et al.
Journal of Bone Oncology
|
December 29, 2018
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
R E Coleman, M Collinson, W Gregory, et al.
Lancet (London, England)
|
February 20, 2007
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
R C Coombes, L S Kilburn, C F Snowdon, et al.
Page
of 10